Scynexis (SCYX) Non Operating Investment Income (2019 - 2024)
Scynexis (SCYX) reported Non Operating Investment Income of $28000.0 for Q2 2024, down 33.33% on a YoY basis from $42000.0 in Q3 2023, and down 83.33% quarter-over-quarter from $168000.0 in Q1 2024.
Scynexis (SCYX) Non Operating Investment Income (2019 - 2024) Analysis & Trends
Scynexis has reported Non Operating Investment Income for 6 years, with the latest figure at $28000.0 in Q2 2024.
- For the quarter ending Q2 2024, Non Operating Investment Income fell 33.33% year-over-year to $28000.0; the trailing twelve-month figure through Mar 2025 stood at $28000.0 (down 93.33% YoY), and the FY2024 full-year result was $196000.0, up 227.27% from the prior year.
- Non Operating Investment Income for Q2 2024 stood at $28000.0, down from $168000.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $5.3 million in Q3 2020, with the low at -$4.4 million in Q4 2020.
- Historically, Non Operating Investment Income has averaged $265833.3 across 5 years, with a median of $175000.0 in 2022.
- Annual changes were most pronounced in 2020 — Non Operating Investment Income sank 429.32% — and 2022, when it jumped 1188.89%.
- Scynexis' Non Operating Investment Income stood at -$4.4 million in 2020, then surged by 86.4% to -$602000.0 in 2021, then soared by 132.56% to $196000.0 in 2022, then sank by 85.71% to $28000.0 in 2023, then changed by 0.0% to $28000.0 in 2024.
- The last three Non Operating Investment Income figures came in at $28000.0 (Q2 2024), $168000.0 (Q1 2024), and $28000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Scynexis | 216.06 Mn | 156.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Sep 30, 2023 | 182,000.00 |
| Sep 30, 2023 | 182,000.00 |
| Jun 30, 2023 | 42,000.00 |
| Jun 30, 2023 | 42,000.00 |
| Mar 31, 2023 | -406,000.00 |
| Mar 31, 2023 | -406,000.00 |
| Dec 31, 2022 | 196,000.00 |
| Dec 31, 2022 | 196,000.00 |
| Sep 30, 2022 | -42,000.00 |
| Sep 30, 2022 | -42,000.00 |
| Jun 30, 2022 | 182,000.00 |
| Jun 30, 2022 | 182,000.00 |
| Mar 31, 2022 | 980,000.00 |
| Mar 31, 2022 | 980,000.00 |